---
title: Cognition in Patients With Memory Difficulties and Dementia Relative to APOE
  e4 Status
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-WMKUFSQW" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Hestad, K., Engedal, K., Horndalsveen, P. O., &#38; Strand, B. H. (2021). Cognition in Patients With Memory Difficulties and Dementia Relative to APOE e4 Status. <i>Frontiers in Psychology</i>, <i>12</i>, 1–7. <a href="https://doi.org/10.3389/fpsyg.2021.686036">https://doi.org/10.3389/fpsyg.2021.686036</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-WMKUFSQW" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=1920718" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/WMKUFSQW" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-WMKUFSQW" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-WMKUFSQW" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-WMKUFSQW" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://www.frontiersin.org/articles/10.3389/fpsyg.2021.686036/pdf" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://www.frontiersin.org/articles/10.3389/fpsyg.2021.686036/pdf" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-WMKUFSQW"></div>
</article>
<div id="csl-bib-meta-WMKUFSQW" class="csl-bib-meta">
  <article id="about-article-WMKUFSQW" class="about_pub-article">
    <h1>Om</h1>
    Hestad et al. gjennomførte ein studie for å undersøke korleis ein spesifikk genvariant, APOE e4, påverkar kognitive evner hos personar med ulike typar minneproblem, inkludert Alzheimers sjukdom og vaskulær demens. Dei undersøkte nesten 2 000 pasientar ved å bruke testar for å måle minne og tenkjeferdigheiter. Funna deira viste at individ med APOE e4-varianten generelt presterte dårlegare på minnetestar samanlikna med dei utan. Jo fleire e4-allelar ein person hadde, desto dårlegare var prestasjonen, spesielt i ordgjenkjenning. Dette mønsteret var konsistent på tvers av ulike typar demens. Å forstå påverknaden av APOE e4 kan hjelpe med å vurdere risiko og tilpasse behandlingar for dei med minnerelaterte tilstandar.
  </article>
  <article id="keywords-article-WMKUFSQW" class="keywords-article">
    <h1>Emneord</h1>
    APOE e4, Kognitiv yting, Subjektiv kognitiv svikt, Mild kognitiv svikt, Alzheimers sjukdom, Vaskulær demens
  </article>
  <article id="abstract-article-WMKUFSQW" class="abstract-article">
    <h1>Samandrag</h1>
    The aim of this study was to investigate whether cognitive performance was equally influenced by Apolipoprotein E (APOE, with its three alleles, e2, e3, and e4) in patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI), and Alzheimer’s disease (AD). In addition, we examined a group of patients with a combination of Vascular dementia (VaD) and AD (VaD/AD). We asked if the APOE e4 allele influenced cognition in these patient groups in the same way. Our study comprised data from 1,991 patients (55% women), with a mean age of 70.9 years (SD 10.8) and 12.1 years of education (SD 3.8). Of them, 1,111 (56%) had at least one APOE e4 allele; 871 (44%) had one and 240 (12%) had two e4 alleles. Three neurocognitive tests were used to measure cognition: the Mini Mental State Examination (MMSE), the 10-word test of the Consortium to Establish a Registry for Alzheimer’s Disease Word List (CERAD-WL) (immediate and delayed recall), and the Trail Making Test Part A (TMTA). The APOE genotypes were regressed against cognitive function using linear regression, adjusting for diagnosis, age, sex, and education. The interaction diagnosis∗APOE was investigated. The allele type had the largest effect on cognitive performance assessed by the CERAD-WL delayed recall test, less for the other tests. Those without the e4 type scored 0.7 units better than those with e4 allele(s) (p < 0.001). Furthermore, there was a significant inverse dose-response pattern between number of e4 alleles and cognitive performance; those with one allele scored 0.4 units better than those with two alleles (p = 0.006), and those without e4 scored 0.7 units better than those with one e4 (p < 0.001). This pattern did not differ between the four diagnostic groups studied.
  </article>
  <article id="sdg-article-WMKUFSQW" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}nn/archive/?sdg=3#archive" class="sdg-publication-count"><span>1377</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-WMKUFSQW" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li><a href="{{< params subfolder >}}nn/archive/?key=3DCRN523">Universitetet i Innlandet</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=IDKFS3MX">Fakultet for helse- og sosialvitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=GTV4ECMZ">Institutt for helse- og sykepleievitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=4IUS5XY3">2021</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=SNWT2FQ9">Juli</a></li>
    </ul>
  </article>
</div>
